The RSV and SARS-CoV-2 Antigen Combo Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of RSV and SARS-CoV-2 infectious diseases in human nasopharyngeal swab specimens as an aid in the diagnostic of RSV and SARS-CoV-2 infectious diseases.

Product Features

RSV (Respiratory Syncytial Virus) and SARS-CoV-2 (the virus that causes COVlD-19) areboth highly contagious respiratory viruses, but they affect populations differently. RSV isa leading cause of severe respiratory illness in infants and older adults, while SARS-CoV-2has caused a global pandemic affecting all age groups. Symptoms of RSV often resemblea common cold but can escalate to bronchiolitis or pneumonia, characterized by severecough, wheezing, and difficulty breathing. In contrast, SARS-CoV-2 infection (COVID-19)presents with a wider range of symptoms, including fever, cough, fatigue, and loss ottaste or smell. While many cases are mild, it can lead to severe pneumonia, acute respira-tory distress syndrome (ARDS), and systemic complications.


Product Advantages:

Fast Results in 15 Minutes

High Accuracy

Easy Visual Interpretation

Convenient Procedure


PRODUCT SPECIFICATION

  • FormatCassette
  • SpecimenNasopharyngeal Swab
  • CertificateCE
  • Reading Time15 minutes
  • Pack10T
  • Storage Temperature 2-30°C
  • SensitivityRSV: 93.2% SARS-CoV-2: 96.4%
  • SpecificityRSV: 98.1% SARS-CoV-2: 99.0%
  • AccuracyRSV: 96.1% SARS-CoV-2: 98.2%

Ordering Information

  • Cat. No.IRSC-502
  • ProductRSV and SARS-CoV-2 Antigen Combo Rapid Test
  • SpecimenNasopharyngeal Swab
  • Pack10 T
  • Cut-Off-